fibrinogen has been researched along with Angor Pectoris in 149 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 62 (41.61) | 18.7374 |
| 1990's | 39 (26.17) | 18.2507 |
| 2000's | 43 (28.86) | 29.6817 |
| 2010's | 5 (3.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, W; Li, Y; Lv, YN; Wei, CD; Zheng, HY | 1 |
| Apostolopoulos, V; Bosevska, G; Bosevski, M; Stojanovska, L | 1 |
| Amouyel, P; Arveiler, D; Bingham, A; Canoui-Poitrine, F; Ducimetiere, P; Empana, JP; Evans, A; Ferrieres, J; Haas, B; Juhan-Vague, I; Luc, G; Montaye, M; Morange, P; Ruidavets, JB | 1 |
| Moresco, RN | 1 |
| Leschke, M | 1 |
| Chen, J; Ge, J; Hu, T; Huang, W; Liu, M; Ma, H; Sun, A; Wang, K; Wang, Y; Wang, Z; Xu, D; Xu, L; Zou, Y | 1 |
| Abd el-Kader, SS; Abu el-Makrem, MA; Ghazaly, T; Mahmoud, YZ; Matta, R; Nassef, NM; Sayed, D; Zakhary, M | 1 |
| Jax, TW; Peters, AJ; Plehn, G; Schoebel, FC | 1 |
| Deev, AD; Metel'skaia, VA; Perova, NV; Ratnikova, LA; Shal'nova, SA; Shkol'nikov, VM; Shkol'nikova, MA | 1 |
| Arefieva, TI; Bespalova, ZhD; Chazov, EI; Gorshkov, BG; Krasnikova, TL; Ksenevich, TI; Kukhtina, NB; Nikitin, PI; Noeva, EA; Potekhina, AV; Provatorov, SI; Ruleva, NU; Sidorova, MV | 1 |
| Chen, Y; Jin, Z; Li, H; Lv, S; Song, X; Xu, F; Yuan, F; Zhou, Y | 1 |
| Dabrowski, M; Gajewski, M; Karpiński, M; Kosior, J; Kubik, L; Pecak, R; Płocharski, A; Skolimowska, B; Stankiewicz, W; Szmigielski, S | 1 |
| Hankey, CR; Lean, ME; Lowe, GD; Rumley, A; Woodward, M | 1 |
| Amouyel, P; Arveiler, D; Bard, JM; Ducimetiere, P; Evans, A; Ferrieres, J; Fruchart, JC; Juhan-Vague, I; Luc, G | 1 |
| FRADKINA, VE | 1 |
| KOZLOVA, VN; SANDLER, RI | 1 |
| KOZHEVNIKOVA, TL | 1 |
| IRANI, MA | 1 |
| BRITOV, AN | 1 |
| BAYLES, TB; FINKELSTEIN, AE; LEVINE, HD; SMITH, JC; WOERNER, TE | 1 |
| EASTHAM, RD; MORGAN, EH | 1 |
| JAROSCHEWSKI, AJ; SHAWORONKOWA, EK | 1 |
| IAROSHEVSKII, AIa; ZHAVORONKOVA, EK | 1 |
| Cesar, LA; Lemos, PA; Mansur, AP; Maranhão, RC; Ramires, JA; Sposito, AC | 1 |
| Diasamidze, IuS; Karandashov, VI; Paleev, NR; Petukhov, EB | 1 |
| Connor, JM; Cooke, A; Fowkes, FG; Lee, AJ; Lowe, GD; Rumley, A; Smith, FB | 1 |
| Alte, D; Felix, SB; John, U; Robinson, DM; Schwahn, C; Völzke, H | 1 |
| Akbulut, M; Arslan, N; Dagli, N; Durukan, P; Gundogdu, O; Ilkay, E; Ozbay, Y | 1 |
| Channer, KS; English, KM; Jones, RD; Jones, TH; Malkin, CJ; Smith, AM | 1 |
| Anvari, A; Falkensammer, C; Gyöngyösi, M; Huber, K; Jordanova, N; Khorsand, A; Wojta, J; Zorn, G | 1 |
| Fomin, VV; Kopelëva, MV; Martynov, AI; Moiseev, SV; Mukhin, NA; Paramonov, AD; Stankevich, LI | 1 |
| Amano, T; Hamaguchi, Y; Hayashi, Y; Ishii, H; Izawa, H; Matsubara, T; Miura, M; Murohara, T; Ogawa, Y; Torigoe, M; Yoshida, T | 1 |
| Adler, Y; Behar, S; Benderly, M; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R | 1 |
| Adler, Y; Behar, S; Benderly, M; Boyko, V; Esper, RJ; Fisman, EZ; Matas, Z; Tanne, D; Tenenbaum, A | 1 |
| Escobar, A; Iriarte, JA; Lafita, M; Magro, A; Molinero, E; Narváez, I; Sáez de Lafuente, JP; Sáez, Y; Sagastagoitia, JD; Santos, M; Vacas, M | 1 |
| Bickel, C; Blankenberg, S; Espinola-Klein, C; Lackner, KJ; Lubos, E; Messow, CM; Münzel, T; Rupprecht, HJ; Schnabel, R; Sinning, JM; Tiret, L | 1 |
| Drömann, D; Geist, V; Khattab, AA; Mier, K; Richardt, G; Röther, C; Schäfer, T; Schwarz, B; Toelg, R | 1 |
| Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Wasserman, S | 1 |
| Boothroyd, D; Fortmann, SP; Go, AS; Hlatky, MA; Iribarren, C; Itakura, H; Leung, LL; Quertermous, T; Sobel, BE | 1 |
| Coma-Canella, I; Martínez de Sizarrondo, S; Orbe, J; Páramo, JA; Rodríguez, JA; Serrano, R; Zudaire, M | 1 |
| Cholmogorow, WE; Ganelina, IE; Kukui, LM; Nikolaewa, JP; Schumilowa, TE; Schurigin, AL; Timofeew, KW | 1 |
| Bertina, R; Briët, E; Kolff, J; van der Laarse, A; van Hulsteijn, H | 1 |
| Cederholm-Williams, S; Copper, S; Cotter, L; O'Connor, NT | 1 |
| Kumar, A; Mehrotra, TN; Mital, HS; Raka, MS; Singh, VS; Sinha, AK | 1 |
| Acciavatti, A; Del Bigo, C; Di Perri, T; Forconi, S; Galigani, C; Guerrini, M; Pieragalli, D | 1 |
| Caprissi, LF; Castellanos, H; de Caprissi, ES; Ruggiero, HA; Ruggiero, LH | 1 |
| Gofferje, H; Horbach, L; Ollenschläger, G; Prestele, H; Schultis, K | 1 |
| Caprissi, ES; Caprissi, LF; Castellanos, H; Ruggiero, HA | 1 |
| den Ottolander, GJ; Houtsmuller, UM; Lussenburg, RN; Turek, JV | 1 |
| Caimi, G; Catania, A; Francavilla, G; La Bruzzo, S; Romano, A; Sarno, A | 1 |
| Baller, D; Gleichmann, U; Mannebach, H; Miche, E; Prohaska, W; Schmidt, H | 1 |
| Heller, W; Hoffmeister, HM; Jur, M; Seipel, L; Wendel, HP | 1 |
| Haverkate, F; Kienast, J; Pyke, SD; Thompson, SG; van de Loo, JC | 1 |
| Agraou, B; Asseman, P; Bauters, C; Cosson, A; Devos, P; Jude, B; Lepelley, P; McFadden, EP; Susen, S; Vanhaesbroucke, C | 1 |
| Jespersen, J; Juhan-Vague, I; Thompson, SG | 1 |
| Branzi, A; Candiotti, N; Cervi, V; Magnani, B; Melandri, G; Palazzini, E; Semprini, F | 1 |
| Accadia, M; Granato Corigliano, G; Spadaro, P | 1 |
| Gratsianskiĭ, NA; Kachalkov, DV | 1 |
| Lee, AJ; Lowe, GD; Tunstall-Pedoe, H; Woodward, M | 1 |
| van de Loo, J | 1 |
| Breithardt, G; Fechtrup, C; Heyse, U; Kienast, J; Squire, E; Thompson, SG; van de Loo, JC | 1 |
| Becker, DJ; Ellis, D; Kuller, LH; Lloyd, CE; Orchard, TJ; Wing, RR | 1 |
| de Bart, AC; de Maat, MP; Havelaar, AC; Hennis, BC; Kluft, C; Meijer, P; Mulder, PG | 1 |
| Jax, TW; Leschke, M; Schoebel, FC; Stein, D; Strauer, BE | 1 |
| Arnold, AE; de Maat, MP; Kluft, C; van Buuren, S; Wilson, JH | 1 |
| Alessi, MC; Haverkate, F; Jespersen, J; Juhan-Vague, I; Pyke, SD; Thompson, SG | 1 |
| Angelin, B; Björkander, I; Forslund, L; Held, C; Hjemdahl, P; Rehnqvist, N; Wallén, NH; Wiman, B | 1 |
| Barradell, LB; Goa, KL; Plosker, GL | 1 |
| Montes, R; Panizo, C; Páramo, JA; Rifón, J; Rocha, E | 1 |
| Fowkes, FG; Lee, AJ; Lowe, GD; Price, JF; Rumley, A; Smith, FB | 1 |
| Heidland, UE; Heintzen, MP; Klimek, WJ; Michel, CJ; Strauer, BE; Willers, R | 1 |
| Chernysheva, GA; Markov, VA; Nevzorov, MS; Plotnikov, MB; Saratikov, AS; Vyshlov, EV | 1 |
| Danielsen, R; Morrissey, JH; Onundarson, PT; Thors, H; Vidarsson, B | 1 |
| Egberg, N; Eriksson, M; Mittleman, MA; Orth-Gomér, K; Schenck-Gustafsson, K; Wamala, S | 1 |
| Dernellis, J; Diamantopoulos, L; Stefanadi, E; Stefanadis, C; Toutouzas, K; Toutouzas, P; Tsiamis, E; Vlachopoulos, C | 1 |
| Curzen, N; Fox, KM; Goodall, AH; Hurd, C; Knight, CJ; Ouwehand, WH; Panesar, M | 1 |
| Borries, M; Fischer, Y; Heins, M; Leschke, M; Peters, A; Reinauer, H; Schoebel, FC; Stiegler, H; Strauer, BE | 1 |
| Assmann, G; Heinrich, J; Junker, R; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
| Björkander, I; Forslund, L; Håkan Wallén, N; Held, C; Hjemdahl, P; Rehnqvist, N; Wiman, B | 1 |
| Ford, ES; Giles, WH | 1 |
| Fleischer, L; Handler, B; Kummerow, FA; Olinescu, RM; Shinkareva, SV | 1 |
| Hedley, AJ; Janus, ED; Lam, TH; Lau, CP; Liu, LJ | 1 |
| Iida, M; Imano, H; Iso, H; Kitamura, A; Kiyama, M; Komachi, Y; Naito, Y; Nakagawa, Y; Nakamura, M; Okamura, T; Sato, S; Shimamoto, T | 1 |
| Chakhtoura, EY; Cohen, AJ; Haft, JI; Obiedzinski, GR; Shamoon, FE; Watson, RM | 1 |
| Droullé, C; Garnotel, R; Hézard, N; Metz, D; Nguyen, P; Potron, G | 1 |
| Alpsoy, S; Ata, N; Cavusoglu, Y; Gorenek, B; Timuralp, B; Unalir, A | 1 |
| Assmann, G; Heinrich, J; Koehler, E; Schulte, H; Tataru, MC; von Eckardstein, A | 1 |
| Bolton, CH; Downs, LG; Dwight, JF; Mackness, MI; Pinkney, JH; Tomson, CR; Victory, JG | 1 |
| Arakawa, K; Isoda, K; Miyake, T; Mizuno, K; Nishikawa, K; Nishizawa, K; Ohsuzu, F; Satomura, K; Shibuya, T; Takase, B | 1 |
| Bogaty, P; Boyer, L; Dagenais, GR; Poirier, P; Simard, S; Solymoss, S | 1 |
| Altamura, N; Di Chiara, A; Fioretti, P; Fiotti, N; Giansante, C; Guarnieri, G; Miccio, M | 1 |
| Dabrowski, M; Loukas, M; Ruzyłło, W; Wagner, T; Walczak, E; Witkowski, A | 1 |
| Adamus, J; Gil, M; Zarebiński, M | 1 |
| Fujii, A; Fujii, K; Fujii, T; Iwami, T; Matsuzaki, M; Ogawa, H; Suzuki, N; Umemoto, S | 1 |
| Alekseeva, IA; Dobrovol'skiĭ, AB; Liakishev, AA; Nasonov, EL; Naumov, VG; Parfenova, EV; Tkachuk, VA | 1 |
| Dormandy, JA | 1 |
| Besterman, EM; Bowers, R; Horbourne, T; Kidner, PH; Nicolaides, AN | 1 |
| Ito, T; Matsui, E; Niwa, T; Sassa, H | 1 |
| Fedorishko, SS; Palamarchuk, VI; Revutskiĭ, EL; Vendt, VP | 1 |
| Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Rossi, C | 1 |
| Chernysheva, LN; Urbaniuk, KG | 1 |
| Froschauer, J; Pimmingstorfer, E; Spöttl, F | 1 |
| Bowers, R; Dupont, PA; Harbourne, T; Kidner, PH; Nicolaides, AN | 1 |
| Neugebauer, G | 1 |
| Baroncini, S; Coccheri, S; De Rosa, V; Donato, S; Pretolani, E; Zoli, I | 1 |
| Bulin, VA; Iliushina, IP; Mazur, NA; Metalitsa, VI; Zhukov, VN | 1 |
| Benda, L; Klösel, W; Redtenbacher, L; Spiess, A; Zenz, W | 1 |
| Haverkate, F; Thompson, SG; van de Loo, JC | 1 |
| Cazenave, JP; Grunebaum, L; Mossard, JM; Sacrez, A; Wiesel, ML | 1 |
| Boschetti, C; Catalano, M; Cofrancesco, E; Cortellaro, M; de Gaetano, G; Gabrielli, L; Lombardi, B; Specchia, G; Tavazzi, L; Zanussi, C | 1 |
| Blanke, H; Höffken, H; Leschke, M; Motz, W; Schöbel, F; Strauer, BE | 1 |
| Barbagallo, M; Catalano, I; Daví, G; Giammarresi, C; Nicolosi, G; Notarbartolo, A; Putignano, E; Violi, F | 1 |
| Ardissino, D; Barberis, P; Bruno, N; Demicheli, G; Gamba, MG; Merlini, PA; Rolla, A; Specchia, G; Testa, S | 1 |
| Bespalko, IA; Lekochmacher, SS; Raskuragev, AB; Shpector, AV; Vasilieva, EJ | 1 |
| Dykun, IaV; Malaia, LT; Shuliak, LN; Topchiĭ, II; Volkov, VI | 1 |
| Buys, EM; Haas, F; Haverkate, F; Hollander-van Zalk, A; Six, AJ; Tjon, RM | 1 |
| Lekhormakher, SS; Orlov, VN; Raskurazhev, AB; Shpektor, AV; Vasil'eva, EIu | 1 |
| Leschke, M; Motz, W; Strauer, BE; Vogt, M | 1 |
| Baur, HR; Gallino, A; Haeberli, A; Straub, PW | 1 |
| Bareiss, P; Cazenave, JP; Drawin, T; Grunebaum, L; Kieny, JR; Mossard, JM; Roul, G; Sacrez, A; Wiesel, ML | 1 |
| Chen, ZJ; Tao, SQ; Yao, SK | 2 |
| Matsuyama, K; Obata, K; Ogawa, H; Okumura, K; Oshima, S; Yasue, H | 1 |
| Cucchi, G; Ferrara, E; Sardeo, C | 1 |
| Fedorishko, SS; Palamarchuk, VI | 1 |
| Swahn, E; von Schenck, H; Wallentin, L | 1 |
| Fratino, P; Grignani, G; Pacchiarini, L; Salerno, JA; Storti, C; Zucchella, M | 1 |
| Tulchinsky, M; Wilensky, RL; Wish, M; Zeller, JA | 1 |
| De Lara, J; Latour, JG; Léger-Gauthier, C; Théroux, P | 1 |
| Caporicci, D; Carloni, MT; Mariani, A; Passarelli Pula, E | 1 |
| Abbate, R; Bonechi, F; Carnovali, M; Casolo, GC; Fazi, A; Gensini, GF; Neri Serneri, GG; Prisco, D; Rogasi, PG | 1 |
| Blanke, H; Leschke, M; Motz, W; Stellwaag, M; Strauer, BE | 1 |
| Abbate, R; Favilla, S; Gensini, GF; Mannucci, PM; Neri Serneri, GG; Rostagno, C | 1 |
| Ambrose, JA; Borrico, S; Cohen, M; Fuster, V; Gorlin, R; Hjemdahl-Monsen, C; Sherman, W | 1 |
| Eroshina, VA; Goliakov, VN; Semiletova, VI; Zimin, IuV | 1 |
| Borodkin, VV; Diukov, IV; Dudaev, VA | 1 |
| Abbate, R; Carnovali, M; Casolo, GC; Fazi, A; Gensini, GF; Neri Serneri, GG; Prisco, D; Rogasi, PG | 1 |
| Bhattacharya, SK; Dube, B; Dube, RK; Somani, PN; Tripathi, GK | 1 |
| Kartsev, AN; Lapotnikov, VA | 1 |
| Chakrabarti, R; Fearnley, GR; Hocking, ED | 1 |
| Liusov, VA | 1 |
| Pavlishchuk, SA; Petrova, TR | 1 |
| Matsuda, T | 1 |
| Benda, L; Redtenbacher, L; Spiess, A; Steinbach, T | 1 |
| Parkhotik, II; Sakharchuk, II | 1 |
| Medvedeva, ZF; Shishkova, TV; Vorob'ev, AI | 1 |
| Sitar, J | 1 |
| Jeziorny, J; Kogucki, S; Laskowski, S; Olszewski, W | 1 |
| Vykouril, J | 1 |
4 review(s) available for fibrinogen and Angor Pectoris
| Article | Year |
|---|---|
[Rheology and coronary heart disease].
Topics: Angina Pectoris; Blood Viscosity; Coronary Circulation; Coronary Disease; Coronary Stenosis; Erythrocyte Aggregation; Fibrinogen; Hemorheology; Humans; Syndrome; Urokinase-Type Plasminogen Activator; Vascular Resistance | 2008 |
Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
Topics: Aged; Angina Pectoris; Antigens, CD; Antigens, Surface; Arterial Occlusive Diseases; Cross-Sectional Studies; Female; Fibrinogen; Humans; Intermittent Claudication; Lectins, C-Type; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; NK Cell Lectin-Like Receptor Subfamily B; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Risk Factors; Scotland; Smoking | 2003 |
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
Topics: Angina Pectoris; Apolipoproteins; Apolipoproteins A; Bezafibrate; Diabetes Complications; Drug Tolerance; Fibrinogen; Glucose; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Male; Myocardial Infarction | 1996 |
[Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation].
Topics: Abciximab; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Blood Platelets; CD18 Antigens; Chemotaxis, Leukocyte; Coronary Artery Bypass; Coronary Disease; Cytokines; Fibrinogen; Heparin; Humans; Immunoglobulin Fab Fragments; Leukocytes; Ligands; Macrophage-1 Antigen; Membrane Glycoproteins; Models, Biological; Myocardial Infarction; Neutrophils; P-Selectin; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombospondins; Tirofiban; Tyrosine | 2000 |
13 trial(s) available for fibrinogen and Angor Pectoris
| Article | Year |
|---|---|
Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.
Topics: Administration, Cutaneous; Androgens; Angina Pectoris; Blood Coagulation; Chronic Disease; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors; Testosterone; Thrombosis; Tissue Plasminogen Activator | 2005 |
Association between inflammation, lipid and hemostatic factors in patients with stable angina.
Topics: Aged; Angina Pectoris; Apolipoprotein A-I; Apolipoprotein B-100; Atherosclerosis; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Lipoprotein(a); Male; Middle Aged; Risk Factors; Triglycerides | 2007 |
Sirolimus-eluting stent treatment as buffer for inflamed lesions identified by serum marker estimation. The STABILISE pilot study.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Centrifugation, Density Gradient; Female; Fibrinogen; Flow Cytometry; Humans; Immunosuppressive Agents; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Male; Membrane Proteins; Pilot Projects; Prospective Studies; Sirolimus; Stents; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2007 |
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Factors; C-Reactive Protein; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; von Willebrand Factor | 1995 |
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Angina Pectoris; Bleeding Time; Cardiovascular Agents; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Fibrinogen; Heparin, Low-Molecular-Weight; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Aggregation | 1993 |
Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Antigens; C-Reactive Protein; Case-Control Studies; Cross-Over Studies; Double-Blind Method; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Reference Values; Ticlopidine | 1996 |
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.
Topics: Adult; Angina Pectoris; Biomarkers; Death, Sudden; Female; Fibrinogen; Fibrinolysis; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Tissue Polypeptide Antigen; von Willebrand Factor | 1996 |
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Thrombosis; Disease Progression; Factor VII; Factor VIIa; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Prospective Studies; Regression Analysis; Risk Assessment; Sex Characteristics; Triglycerides | 1998 |
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; beta-Thromboglobulin; Calcium Channel Blockers; Cardiovascular Diseases; Double-Blind Method; Female; Fibrinogen; Hemostasis; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Multivariate Analysis; Orosomucoid; Prognosis; Verapamil | 2000 |
The relationship of oxidized lipids to coronary artery stenosis.
Topics: Adult; Age Distribution; Aged; Angina Pectoris; Antioxidants; Biomarkers; Cardiac Catheterization; Ceruloplasmin; Cholesterol; Female; Fibrinogen; Humans; Leukocytes, Mononuclear; Lipid Peroxidation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Probability; Risk Assessment; Sex Distribution | 2000 |
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Factor VII; Factor VIII; Female; Fibrinogen; Hemostasis; Humans; Ischemia; Ischemic Attack, Transient; Male; Middle Aged; Myocardial Infarction; Thrombosis; Vascular Diseases | 1992 |
Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: a controlled cross-over randomized study.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Drug Administration Schedule; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Patient Compliance; Random Allocation; Thrombosis | 1988 |
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Topics: Adult; Aged; Angina Pectoris; Biguanides; Blood Coagulation Tests; Cholesterol; Ethylestrenol; Female; Fibrinogen; Humans; Intermittent Claudication; Male; Metformin; Middle Aged; Myocardial Infarction; Phenformin; Placebos; Vascular Diseases | 1967 |
132 other study(ies) available for fibrinogen and Angor Pectoris
| Article | Year |
|---|---|
The roles of a novel anti-inflammatory factor, milk fat globule-epidermal growth factor 8, in patients with coronary atherosclerotic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Antigens, Surface; C-Reactive Protein; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus; Female; Fibrinogen; Humans; Male; Middle Aged; Milk Proteins; Myocardial Infarction; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Triglycerides | 2014 |
CRP and fibrinogen imply clinical outcome of patients with Type-2 diabetes and coronary artery disease.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fibrinogen; Humans; Inflammation; Prognosis; Prospective Studies | 2017 |
Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study.
Topics: Acute Coronary Syndrome; Angina Pectoris; Biomarkers; Epidemiologic Methods; Fibrin Fibrinogen Degradation Products; Fibrinogen; France; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Northern Ireland; von Willebrand Factor | 2008 |
D-dimer and inflammatory biomarkers in stable angina.
Topics: Angina Pectoris; Apolipoprotein A-I; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Inflammation; Sensitivity and Specificity | 2009 |
Association between -455G/A and fibrinogen in a Chinese population.
Topics: Acute Coronary Syndrome; Alleles; Angina Pectoris; Case-Control Studies; China; Coronary Artery Disease; Female; Fibrinogen; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Risk Assessment; Statistics as Topic | 2009 |
The role of platelets CD40 ligand (CD154) in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Angina Pectoris; Angina, Unstable; Blood Platelets; Case-Control Studies; CD40 Ligand; Female; Fibrinogen; Humans; Lipoproteins, LDL; Male; Middle Aged; Models, Biological; Myocardial Infarction; Nitric Oxide; P-Selectin | 2009 |
Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.
Topics: Acute Coronary Syndrome; Angina Pectoris; Blood Viscosity; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Erythrocyte Aggregation; Fibrinogen; Fibrinolysis; Follow-Up Studies; Hemorheology; Humans; Hypercholesterolemia; Incidence; Myocardial Infarction; Myocardial Revascularization; Plasminogen Inactivators; Risk Factors; Thrombophilia | 2009 |
[Relationship between activity of fibrinolysis, parameters of lipid spectrum and carbohydrate metabolism].
Topics: Aged; Angina Pectoris; Atherosclerosis; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Chi-Square Distribution; Cohort Studies; Data Interpretation, Statistical; Female; Fibrinogen; Fibrinolysis; Humans; Hypertension; Insulin; Lipids; Male; Myocardial Infarction; Myocardial Ischemia; Obesity, Abdominal; Prospective Studies; Sex Factors | 2010 |
Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting.
Topics: Acute-Phase Reaction; Aged; Angina Pectoris; Angioplasty; Anti-Inflammatory Agents; C-Reactive Protein; Chemokine CCL2; Coronary Angiography; Coronary Restenosis; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Monocytes; Myocardial Ischemia; Peptide Fragments; Protein Binding; Protein Structure, Tertiary; Stents | 2011 |
Macrophage inflammatory protein-1β and fibrinogen are synergistic predictive markers of prognosis of intermediate coronary artery lesions.
Topics: Aged; Angina Pectoris; Biomarkers; Chemokine CCL4; Coronary Stenosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Risk Factors; Survival Analysis | 2012 |
[Selected inflammatory markers in patients with acute coronary syndrome].
Topics: Adult; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Cytokines; Female; Fibrinogen; Humans; Hyperlipidemias; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-2; Interleukin-6; Male; Middle Aged; Sialoglycoproteins; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2002 |
Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.
Topics: Angina Pectoris; Blood Coagulation; Cholesterol; Erythrocyte Aggregation; Factor VII; Female; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Obesity; Plasminogen Activator Inhibitor 1; Triglycerides; Weight Loss | 2002 |
C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Fibrinogen; France; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Northern Ireland; Prospective Studies; Risk Factors; Statistics, Nonparametric | 2003 |
[Prothrombin and fibrinogen levels in myocardial infarct and stenocardia].
Topics: Angina Pectoris; Fibrinogen; Humans; Myocardial Infarction; Prothrombin | 1956 |
[Clinical significance of fibrinogen test in myocardial infarction and stenocardia].
Topics: Angina Pectoris; Cardiovascular Diseases; Coagulants; Fibrinogen; Humans; Myocardial Infarction | 1958 |
[Studies on fibrinolytic activity and fibrinogen in the blood in atherosclerosis of the coronary vessels, myocardial infarction and during seizures of stenocardia].
Topics: Angina Pectoris; Atherosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Fibrinolysis; Humans; Myocardial Infarction; Seizures | 1961 |
[Simplified method for the determination of fibrinogen in the plasma in myocardial infarct and stenocardia].
Topics: Angina Pectoris; Coagulants; Fibrinogen; Hemostatics; Humans; Myocardial Infarction | 1963 |
[THE IMPORTANCE OF INDICES OF PROTEIN AND LIPID METABOLISM FOR THE DIFFERENTIAL DIAGNOSIS OF VARIOUS FORMS OF CORONARY INSUFFICIENCY].
Topics: Angina Pectoris; Blood Protein Electrophoresis; Cholesterol; Coronary Disease; Diagnosis, Differential; Fibrinogen; Glycoproteins; Humans; Lipid Metabolism; Lipids; Lipoproteins; Myocardial Infarction; Phospholipids | 1963 |
ABNORMAL GLOBULINS IN MYOCARDIAL INFARCTION. WITH SPECIAL REFERENCE TO A MATERIAL COATING ERYTHROCYTES AND A COLD-INSOLUBLE PROTEIN.
Topics: Angina Pectoris; Blood Protein Disorders; Blood Protein Electrophoresis; Blood Sedimentation; Capillaries; Conjunctiva; Cryoglobulins; Dextrans; Erythrocyte Aggregation; Erythrocytes; Fibrinogen; Hemagglutination; Humans; Latex Fixation Tests; Microscopy; Myocardial Infarction; Serologic Tests | 1963 |
PLASMA-FIBRINOGEN LEVELS IN CORONARY-ARTERY DISEASE.
Topics: Angina Pectoris; Anticoagulants; Arteries; Blood Coagulation Tests; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Pulmonary Edema; Pulmonary Embolism; Thrombophlebitis | 1963 |
[COAGULATION AND ANTICOAGULATION FACTORS IN THE BLOOD AND THEIR ALTERATION IN DISORDERS OF CORONARY CIRCULATION].
Topics: Angina Pectoris; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Circulation; Coronary Disease; Fibrinogen; Fibrinolysin; Heparin; Humans; Myocardial Infarction; Niacin; Statistics as Topic | 1963 |
[COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
Topics: Angina Pectoris; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Coronary Circulation; Coronary Disease; Drug Therapy; Factor VII; Fibrinogen; Fibrinolysis; Heparin; Myocardial Infarction; Niacin; Prothrombin Time; Toxicology | 1964 |
The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Apolipoprotein A-I; Biomarkers; Blood Glucose; Blood Pressure; Brazil; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Angiography; Coronary Artery Disease; Diastole; Female; Fibrinogen; Humans; Leukocyte Count; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Retrospective Studies; Statistics as Topic; Systole; Triglycerides | 2003 |
[Phototherapy of hemorheological disorders in coronary failure].
Topics: Aged; Angina Pectoris; Blood Viscosity; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Male; Phototherapy; Ultraviolet Therapy | 2003 |
Plasma fibrinogen levels are associated with a strong family history of myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Apolipoprotein A-I; Case-Control Studies; Comorbidity; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Genetic Predisposition to Disease; Germany; Humans; Male; Middle Aged; Myocardial Infarction; Parents; Risk Factors; Sampling Studies; Siblings | 2004 |
Effects of tirofiban on acute systemic inflammatory response in elective percutaneous coronary interventions.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon; C-Reactive Protein; Coronary Angiography; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-1; Interleukin-6; Interleukin-8; Leukocyte Count; Male; Middle Aged; Myocardium; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Tirofiban; Troponin; Tumor Necrosis Factor-alpha; Tyrosine | 2004 |
New cut-off values of cardiac markers for risk stratification of angina pectoris.
Topics: Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Creatine Kinase; Creatine Kinase, MB Form; Female; Fibrinogen; Humans; Isoenzymes; Male; Middle Aged; Prospective Studies; Recurrence; Risk Assessment; ROC Curve; Troponin I; Troponin T | 2005 |
[Ferritin and other acute phase proteins in various forms of coronary heart disease].
Topics: Aged; Angina Pectoris; Angina, Unstable; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Disease; Echocardiography; Female; Ferritins; Fibrinogen; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors | 2005 |
Impact of plasma aldosterone levels for prediction of in-stent restenosis.
Topics: Aged; Aldosterone; Angina Pectoris; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Angiography; Coronary Restenosis; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Natriuretic Peptide, Brain; Postoperative Complications; Prospective Studies; Regression Analysis; Renin; ROC Curve; Stents | 2006 |
C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease.
Topics: Aged; Angina Pectoris; Bezafibrate; Brain Ischemia; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Incidence; Israel; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment | 2006 |
Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and/or healed myocardial infarction.
Topics: Aged; Angina Pectoris; Blood Glucose; Body Mass Index; Case-Control Studies; Death, Sudden, Cardiac; Female; Fibrinogen; Follow-Up Studies; Humans; Interleukin-6; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Factors; Smoking | 2006 |
Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Coronary Stenosis; Disease-Free Survival; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Risk Factors | 2006 |
In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
Topics: Acute Disease; Aged; Angina Pectoris; Biomarkers; C-Reactive Protein; Chronic Disease; Female; Fibrinogen; Humans; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Matrix Metalloproteinase 9; Middle Aged; Myocardial Ischemia; Odds Ratio; Predictive Value of Tests; Prospective Studies; Receptors, Interleukin-1; Reproducibility of Results; Research Design; ROC Curve; Sensitivity and Specificity; Syndrome; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Treatment Outcome; Ventricular Remodeling | 2007 |
Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Topics: Analysis of Variance; Angina Pectoris; Biomarkers; Blood Coagulation Factors; Case-Control Studies; Cohort Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genotype; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator | 2007 |
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Blood Coagulation; Blood Coagulation Tests; C-Reactive Protein; Case-Control Studies; Chronic Disease; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombin; Time Factors; Up-Regulation | 2008 |
[Therapy of severe stenocardia with ultraviolet blood irradiation (UVB) and various action mechanisms of this therapy].
Topics: Adult; Aged; Angina Pectoris; Antistreptolysin; Blood; Blood Coagulation; Capillary Permeability; Erythrocyte Aggregation; Fibrinogen; Humans; Male; Middle Aged; Nitroglycerin; Ultraviolet Therapy | 1982 |
Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction; Myocardium; Thrombin; Thrombophlebitis | 1984 |
Hypercoagulability and coronary artery disease.
Topics: Adult; Angina Pectoris; Blood Coagulation Disorders; Blood Coagulation Factors; Coronary Disease; Fibrinogen; Fibrinolysis; Humans; Lipids; Male; Middle Aged; Plasminogen Activators; Risk | 1984 |
Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in angina pectoris before and after propranolol therapy.
Topics: Adult; Angina Pectoris; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Platelet Adhesiveness; Propranolol | 1983 |
[Hemorrheological changes in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Erythrocytes; Exercise Test; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Rheology | 1983 |
Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Female; Fibrinogen; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Whole Blood Coagulation Time | 1983 |
[Stress-metabolism after myocardial infarction-demonstrated by means of the behaviour of plasma proteins with short half-life (author's transl)].
Topics: Aged; alpha 1-Antitrypsin; Angina Pectoris; Blood Proteins; C-Reactive Protein; Electrocardiography; Female; Fibrinogen; Half-Life; Haptoglobins; Humans; Male; Myocardial Infarction; Prealbumin; Serum Albumin; Stress, Physiological; Transferrin | 1981 |
Heparin effect on blood viscosity.
Topics: Adult; Aged; Angina Pectoris; Blood Proteins; Blood Viscosity; Female; Fibrinogen; Hematocrit; Heparin; History, 17th Century; Humans; Male; Myocardial Infarction | 1982 |
Effect of low cholesterol, linoleic acid enriched diet on thrombotic tendency and plasma lipoproteins in patients with angina pectoris.
Topics: Aged; Angina Pectoris; Cholesterol, Dietary; Female; Fibrinogen; Hematocrit; Humans; Linoleic Acids; Lipoproteins; Male; Middle Aged; Platelet Aggregation | 1980 |
[Blood viscosimetric factors in cardiovascular pathology].
Topics: Angina Pectoris; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Viscosity; Cardiovascular Diseases; Diabetic Angiopathies; Fibrinogen; Hematocrit; Humans; Leg; Myocardial Infarction; Vascular Diseases | 1980 |
[Fibrinogen and leukocyte number in coronary heart disease. Correlation with angiography and clinical degree].
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction | 1995 |
Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Angina, Unstable; Blood Coagulation; Female; Fibrinogen; Fibrinolysis; Humans; Kallikrein-Kinin System; Male; Middle Aged; Physical Exertion | 1995 |
Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angina, Unstable; Blood Coagulation; Female; Fibrinogen; Humans; Male; Middle Aged; Monocytes; Myocardial Infarction; Peptide Fragments; Prospective Studies; Prothrombin; Thromboplastin; Time Factors | 1994 |
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Topics: Adult; Aged; Aging; Angina Pectoris; Body Mass Index; Coronary Disease; Factor VIII; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Risk Factors; Triglycerides; von Willebrand Factor | 1993 |
[Biochemical-physical and rheologic changes in the blood of patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Animals; Blood Viscosity; Coronary Disease; Cricetinae; Erythrocyte Deformability; Female; Fibrinogen; Hematocrit; Humans; Intermittent Claudication; Male; Middle Aged | 1993 |
[Newly occurring stenocardia: the role of fibrinogen in the prognosis of a clinical remission over the course of a 1- to 1.5-year follow-up].
Topics: Adult; Age Factors; Angina Pectoris; Chi-Square Distribution; Discriminant Analysis; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Remission Induction; Time Factors | 1993 |
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.
Topics: Adult; Angina Pectoris; Cerebrovascular Disorders; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus; Family; Female; Fibrinogen; Heart Diseases; Humans; Hypertension; Intermittent Claudication; Male; Middle Aged; Myocardial Infarction; Risk Factors; Sex Factors | 1993 |
Circulating factors of the haemostatic systems as indicators of increased or reduced coronary risk.
Topics: Angina Pectoris; Blood Coagulation Factors; C-Reactive Protein; Cholesterol; Coronary Disease; Fibrinogen; Follow-Up Studies; Humans; Risk Factors; Tissue Plasminogen Activator; von Willebrand Factor | 1995 |
Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Antithrombin III; Female; Fibrinogen; Follow-Up Studies; Hemostasis; Humans; Male; Middle Aged; Prognosis | 1996 |
Coronary artery disease in IDDM. Gender differences in risk factors but not risk.
Topics: Adolescent; Adult; Age of Onset; Angina Pectoris; Body Constitution; Comorbidity; Coronary Disease; Depression; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Fibrinogen; Follow-Up Studies; Humans; Hypertension; Hypertriglyceridemia; Lipids; Male; Motor Activity; Myocardial Infarction; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Smoking | 1996 |
Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; C-Reactive Protein; Fibrinogen; Humans; Middle Aged; Plasminogen Inactivators; Tissue Plasminogen Activator | 1996 |
Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
Topics: Aged; Angina Pectoris; Blood Viscosity; Coronary Disease; Drug Administration Schedule; Drug Resistance; Exercise Tolerance; Female; Fibrinogen; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1996 |
Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.
Topics: Angina Pectoris; Biomarkers; Case-Control Studies; Circadian Rhythm; Epinephrine; Exercise Test; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Inflammation; Leukocyte Count; Lipids; Male; Middle Aged; Orosomucoid; Plasminogen Activator Inhibitor 1; Platelet Count; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sex Factors; Sweden; Tissue Plasminogen Activator | 1997 |
The increase of plasminogen activator inhibitor activity is associated with graft occlusion in patients undergoing aorto-coronary bypass surgery.
Topics: Angina Pectoris; Coronary Artery Bypass; Female; Fibrinogen; Fibrinolysis; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Risk Factors | 1997 |
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
Topics: Aged; Angina Pectoris; Biomarkers; Blood Proteins; Cerebrovascular Disorders; Cholesterol, LDL; Cohort Studies; Comorbidity; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Heart Diseases; Humans; Hypertension; Incidence; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Scotland; Smoking; Tissue Plasminogen Activator; von Willebrand Factor | 1997 |
[Acute coronary vessel occlusion after PTCA--possibility of risk stratification using quantitative coronary angiography, clinical determinants and laboratory chemistry parameters].
Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Retrospective Studies; Risk Factors | 1997 |
[Rheological and hydrodynamic properties of blood from patients with stable angina pectoris: correction with high molecular polyethylene oxide].
Topics: Adult; Aged; Angina Pectoris; Blood Flow Velocity; Blood Viscosity; Erythrocyte Aggregation; Fibrinogen; Follow-Up Studies; Hematocrit; Hemorheology; Humans; Middle Aged; Polyethylene Glycols; Surface-Active Agents | 1998 |
Relationship between plasma fibrinogen and coronary heart disease in women.
Topics: Adult; Aged; Angina Pectoris; Body Mass Index; C-Reactive Protein; Case-Control Studies; Coronary Disease; Female; Fibrinogen; Hospitalization; Humans; Lipids; Logistic Models; Menopause; Middle Aged; Myocardial Infarction; Reference Values; Risk Factors; Smoking | 1999 |
Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter.
Topics: Aged; Angina Pectoris; Angina, Unstable; Animals; Blood Proteins; Body Temperature; C-Reactive Protein; Cardiac Catheterization; Coronary Artery Disease; Coronary Vessels; Disease Progression; Energy Metabolism; Female; Fibrinogen; Humans; Lipids; Macrophage Activation; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Rupture, Spontaneous; Swine; Thermography | 1999 |
Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease.
Topics: Aged; Alleles; Angina Pectoris; Blood Platelets; DNA; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Proline; Protein Binding | 1999 |
Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombin III; beta-Thromboglobulin; Coronary Angiography; Endothelins; Fibrinogen; Fibrinolysis; Hemostasis; Heparin; Humans; Male; Middle Aged; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Prothrombin; Recurrence; Treatment Failure | 1999 |
D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Angina Pectoris; Aorta, Abdominal; Arteriosclerosis; Biomarkers; Blood Viscosity; C-Reactive Protein; Carotid Arteries; Cerebral Arteries; Enzyme-Linked Immunosorbent Assay; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Plasminogen; Plasminogen Activator Inhibitor 1; Prognosis; Severity of Illness Index; Stroke Volume; Ultrasonography, Doppler, Duplex; Ultrasonography, Doppler, Transcranial; Ventricular Function, Left | 1999 |
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III.
Topics: Adult; Angina Pectoris; C-Reactive Protein; Cross-Sectional Studies; Female; Fibrinogen; Humans; Logistic Models; Male; Myocardial Infarction; Predictive Value of Tests; Risk Factors | 2000 |
Fibrinogen, angina and coronary heart disease in a Chinese population.
Topics: Adult; Age Distribution; Aged; Aging; Analysis of Variance; Angina Pectoris; Asian People; China; Coronary Disease; Cross-Sectional Studies; Female; Fibrinogen; Hong Kong; Humans; Incidence; Linear Models; Male; Middle Aged; Multivariate Analysis; Population Surveillance; Risk Factors; Sex Distribution; Survival Rate | 2000 |
Plasma fibrinogen and coronary heart disease in urban Japanese.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Risk Factors; Sex Factors; Urban Population | 2000 |
Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings.
Topics: Aged; Angina Pectoris; Angina, Unstable; Antigens, CD; Coronary Angiography; Female; Fibrinogen; Flow Cytometry; Humans; Male; Platelet Activation; Platelet Membrane Glycoproteins; Risk Assessment; Tetraspanin 30 | 2000 |
Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
Topics: Angina Pectoris; Antithrombin III; C-Reactive Protein; Coronary Angiography; Coronary Disease; Female; Fibrinogen; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Risk Factors; Serine Proteinase Inhibitors; Smoking | 2001 |
Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Arterial Occlusive Diseases; Arteriosclerosis; Cerebrovascular Disorders; Cross-Sectional Studies; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Retrospective Studies; Severity of Illness Index | 2001 |
Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.
Topics: Adult; Angina Pectoris; Autoantibodies; Blood Pressure; C-Reactive Protein; Cell Adhesion Molecules; Cholesterol, HDL; Creatinine; Cross-Sectional Studies; Cytokines; Endothelium, Vascular; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Kidney Failure, Chronic; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Reference Values; Renal Dialysis; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vasodilation; von Willebrand Factor | 2001 |
Relation between plasma fibrinogen level and coronary plaque morphology in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Angioscopy; Coronary Artery Disease; Coronary Vessels; Female; Fibrinogen; Humans; Male; Middle Aged | 2001 |
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.
Topics: Angina Pectoris; Biomarkers; C-Reactive Protein; Female; Fibrinogen; Follow-Up Studies; Homocysteine; Humans; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Plasminogen Activator Inhibitor 1; Recurrence; Tissue Plasminogen Activator; von Willebrand Factor | 2001 |
Coagulation indicators in chronic stable effort angina and unstable angina: relationship with acute phase reactants and clinical outcome.
Topics: Acute-Phase Proteins; Aged; Angina Pectoris; Angina, Unstable; Biomarkers; Blood Proteins; C-Reactive Protein; Chronic Disease; Death, Sudden, Cardiac; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Neoplasm Proteins; Peptide Fragments; Peroxidases; Peroxiredoxin III; Peroxiredoxins; Physical Exertion; Prognosis; Protein Isoforms; Prothrombin; Risk Factors; Treatment Outcome; Troponin I | 2002 |
Fibrinogen and smooth muscle cell detection in atherosclerotic plaques from stable and unstable angina -- an immunohistochemical study.
Topics: Analog-Digital Conversion; Angina Pectoris; Angina, Unstable; Arteriosclerosis; Atherectomy, Coronary; Cell Count; Cell Division; Cell Movement; Coronary Thrombosis; Female; Fibrinogen; Humans; Image Processing, Computer-Assisted; Male; Muscle, Smooth, Vascular | 2002 |
Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina.
Topics: Acute Disease; Adult; Aged; Angina Pectoris; Biomarkers; Cohort Studies; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Poland; Rest; Statistics as Topic; Syndrome; Troponin I | 2002 |
Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris.
Topics: Angina Pectoris; Angina Pectoris, Variant; C-Reactive Protein; Case-Control Studies; Coronary Vasospasm; Eosinophils; Female; Fibrinogen; Humans; Leukocyte Count; Male; Middle Aged; Risk Factors | 2000 |
[Acute phase proteins and recurrence of angina after effective coronary angioplasty].
Topics: Acute-Phase Proteins; Adult; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Restenosis; Factor Analysis, Statistical; Female; Fibrinogen; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Predictive Value of Tests; Recurrence; Risk Factors | 2002 |
Letter: Hyperviscosity angina.
Topics: Angina Pectoris; Blood Viscosity; Fibrinogen; Humans; Intermittent Claudication | 1975 |
Blood viscosity, red-cell flexibility, haematocrit, and plasma-fibrinogen in patients with angina.
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Clofibrate; Erythrocytes, Abnormal; Fibrinogen; Hematocrit; Humans; Male; Middle Aged | 1977 |
Fibrinolysis in patients with ischemic heart disease (in relation to the etiologic factor of myocardial infarction).
Topics: Acute Disease; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Lipids; Middle Aged; Myocardial Infarction; Plasminogen; Serum Globulins; Streptokinase | 1975 |
[Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Chronic Disease; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Protein Binding; Sterols | 1979 |
[Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
Topics: Adult; Angina Pectoris; Arterial Occlusive Diseases; Blood Viscosity; Chronic Disease; Coronary Disease; Diabetic Angiopathies; Diabetic Retinopathy; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Myocardial Infarction; Osmotic Fragility | 1977 |
[Nonenzymatic fibrinolysis in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Epinephrine; Fibrinogen; Fibrinolysis; Heparin; Humans; Middle Aged; Myocardial Infarction | 1978 |
[Therapeutic defibrination by arwin in unstable angina pectoris combined with hyperfibrinogenaemia (author's transl)].
Topics: Ancrod; Angina Pectoris; Antibody Formation; Blood Protein Disorders; Fibrinogen; Humans; Infusions, Parenteral; Injections, Subcutaneous; Male | 1978 |
Proceedings: Blood viscosity, red cell flexibility and plasma fibrinogen in patients with angina.
Topics: Adult; Aged; Angina Pectoris; Blood Viscosity; Erythrocytes; Fibrinogen; Hematocrit; Humans; Middle Aged | 1976 |
[Improvement of flow properties using Arwin in acute experimental infarct].
Topics: Angina Pectoris; Animals; Anticoagulants; Blood Pressure; Blood Viscosity; Dogs; Female; Fibrinogen; Heart Rate; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Snakes; Venoms | 1976 |
[New therapeutic possibilities in the field of coronary disease].
Topics: Adult; Aged; Angina Pectoris; Benzofurans; Benzyl Alcohols; Blood Coagulation; Coronary Circulation; Coronary Disease; Female; Fibrinogen; Glycogen; Heart; Humans; Lipids; Male; Middle Aged; Myocardium; Oxygen Consumption; Vasodilator Agents; Water-Electrolyte Balance | 1975 |
[Survival and state of patients during the 1st year after myocardial infarct (according to data of epidemiological study - myocardial infarct register)].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Blood Glucose; Cholesterol; Fibrinogen; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Prognosis; Recurrence; Thrombelastography; Thromboembolism; Time Factors | 1975 |
[Fibrinolysis and anticoagulants in severe angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Anticoagulants; Blood Viscosity; Female; Fibrinogen; Fibrinolysis; Hematocrit; Humans; Male; Middle Aged; Platelet Adhesiveness | 1976 |
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Topics: Angina Pectoris; beta-Thromboglobulin; Blood Coagulation Tests; Coronary Artery Disease; Cross-Sectional Studies; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Plasminogen Inactivators; Platelet Factor 4; Risk Factors; Thrombosis; Tissue Plasminogen Activator | 1992 |
[Variations of plasma Willebrand factor and fibrinogen in coronary pathology].
Topics: Angina Pectoris; Biomarkers; Coronary Disease; Fibrinogen; Humans; Middle Aged; Myocardial Infarction; von Willebrand Factor | 1992 |
[Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
Topics: Aged; Angina Pectoris; Blood Viscosity; Chronic Disease; Coronary Disease; Drug Evaluation; Exercise Test; Fibrinogen; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Radionuclide Imaging; Thallium Radioisotopes; Time Factors; Urokinase-Type Plasminogen Activator | 1992 |
Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Topics: Adult; Aged; Angina Pectoris; Antithrombin III; Coronary Disease; Diabetes Mellitus, Type 2; Exercise Test; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Peptide Hydrolases; Plasminogen Inactivators; Tissue Plasminogen Activator | 1991 |
Fibrinopeptide A excretion in urine: a marker of the cumulative thrombin activity in stable versus unstable angina patients.
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Coronary Angiography; Coronary Thrombosis; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Thrombin | 1991 |
Platelet function and plasma lipid levels in patients with stable and unstable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Electrocardiography; Female; Fibrinogen; Humans; Male; Middle Aged; Platelet Aggregation; Triglycerides; von Willebrand Factor | 1991 |
[The content of fibronectin, fibrinogen, its degradation products and myoglobin in patients with ischemic heart disease].
Topics: Adult; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibronectins; Humans; Male; Myocardial Infarction; Myoglobin; Physical Exertion; Thrombolytic Therapy; Time Factors | 1990 |
The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Topics: Angina Pectoris; Angiography; Angioplasty, Balloon, Coronary; Antigens; Antithrombin III; beta-Thromboglobulin; Blood Cell Count; Blood Coagulation Tests; Coronary Angiography; Factor VIII; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Middle Aged; Plasminogen; Platelet Factor 4; Proteins; Tissue Plasminogen Activator; von Willebrand Factor | 1990 |
[Characteristics of disorders of hemostasis and lipid metabolism in patients with different pathogenetic forms of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Fibrinogen; Hematocrit; Hemostasis; Humans; Lipid Metabolism; Lipids; Male; Middle Aged; Platelet Aggregation; Triglycerides; von Willebrand Factor | 1990 |
Blood rheology as a contributing factor in reduced coronary reserve in systemic hypertension.
Topics: Angina Pectoris; Blood Pressure; Blood Viscosity; Coronary Circulation; Coronary Vessels; Female; Fibrinogen; Hematocrit; Humans; Hypertension; Male; Middle Aged; Plasma; Rheology; Vascular Resistance | 1990 |
Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia.
Topics: Angina Pectoris; Beta-Globulins; beta-Thromboglobulin; Blood Coagulation; Fibrinogen; Fibrinopeptide A; Humans; Myocardial Infarction | 1985 |
[Relation of an increase of von Willebrand factor in the blood, acute myocardial infarction, unstable angina and coronary thrombosis].
Topics: Adult; Angina Pectoris; Angina, Unstable; Coronary Disease; Coronary Thrombosis; Creatine Kinase; Factor VII; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Tissue Plasminogen Activator; von Willebrand Factor | 1989 |
Fibrinolytic activity in coronary heart disease.
Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen | 1989 |
Circadian variation of plasma fibrinopeptide A level in patients with variant angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; beta-Thromboglobulin; Circadian Rhythm; Electrocardiography, Ambulatory; Female; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Male; Middle Aged; Physical Exertion; Platelet Factor 4 | 1989 |
[Fibrinogen, a cardiovascular risk factor].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Fibrinogen; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Risk Factors | 1989 |
[Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
Topics: Angina Pectoris; Coronary Disease; Drug Evaluation; Drug Therapy, Combination; Female; Fibrinogen; Humans; Hypolipidemic Agents; Male; Middle Aged; Sterols; Time Factors | 1989 |
Plasma fibrinogen in unstable coronary artery disease.
Topics: Angina Pectoris; Angina, Unstable; Body Weight; Coronary Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Orosomucoid; Smoking | 1989 |
Fibrinopeptide A levels in patients with acute ischaemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Myocardial Infarction | 1989 |
Urinary fibrinopeptide A levels in ischemic heart disease.
Topics: Angina Pectoris; Angina, Unstable; Coronary Disease; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1989 |
Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Angina Pectoris; Angina, Unstable; beta-Thromboglobulin; Coronary Angiography; Fibrinogen; Fibrinopeptide A; Heart Ventricles; Humans; Physical Exertion; Platelet Aggregation; Platelet Factor 4; Thromboxane B2; Time Factors | 1987 |
[Diltiazem in unstable angina: a therapeutic proposal].
Topics: Adult; Angina Pectoris; Angina, Unstable; beta-Thromboglobulin; Diltiazem; Drug Evaluation; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged | 1988 |
[Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?].
Topics: Angina Pectoris; Angina, Unstable; Blood Viscosity; Cardiac Catheterization; Coronary Angiography; Erythrocyte Aggregation; Fibrinogen; Hemodynamics; Humans; Myocardial Infarction | 1988 |
Increased protein C and fibrinopeptide A concentration in patients with angina.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Fibrinogen; Fibrinopeptide A; Humans; Middle Aged; Protein C | 1988 |
Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiography; Coronary Circulation; Electrocardiography; Female; Fibrinogen; Heparin; Humans; Injections; Male; Middle Aged; Myocardial Infarction; Streptokinase; Subtraction Technique | 1987 |
[Fibrinolytic activity and coronary heart disease].
Topics: Adult; Angina Pectoris; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Plasminogen; Plasminogen Activators | 1987 |
[Hemostasis in ischemic heart disease patients undergoing hyperbaric oxygenation].
Topics: Aged; Angina Pectoris; Coronary Disease; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemostasis; Humans; Hyperbaric Oxygenation; Middle Aged; Platelet Aggregation; Prothrombin; Thrombelastography | 1986 |
[Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
Topics: Adult; Angina Pectoris; Blood Protein Electrophoresis; Chromatography, Gel; Coronary Artery Disease; Coronary Disease; Exercise Therapy; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion | 1986 |
Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study.
Topics: Adult; Aged; Angina Pectoris; Female; Fibrinogen; Fibrinopeptide A; Humans; Male; Middle Aged; Prospective Studies; Time Factors | 1987 |
Plasma fibrinogen, fibrinolytic activity and serum fibrinogen/fibrin degradation products in ischaemic heart disease.
Topics: Angina Pectoris; Coronary Disease; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Male; Myocardial Infarction; Prognosis | 1985 |
[Characteristics of labelled fibrinogen catabolism in hypertension patients].
Topics: Angina Pectoris; Arteriosclerosis; Fibrinogen; Humans; Hypertension; Iodine Radioisotopes | 1985 |
[State of the blood coagulation system in patients with myocardial infarct and chest pain and the changes in it during the use of anticoagulants and fibrinolysin].
Topics: Aged; Angina Pectoris; Anticoagulants; Blood Coagulation; Factor V; Factor VII; Female; Fibrinogen; Fibrinolysin; Heparin; Humans; Male; Methods; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography | 1967 |
[Pathogenetic aspects of cellular hemostasis in ischemic heart disease].
Topics: Adenosine Diphosphate; Angina Pectoris; Arteriosclerosis; Basophils; Blood Coagulation; Blood Platelets; Coronary Disease; Fibrinogen; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation | 1974 |
[Fibrinogen-fibrin degradation products (FDP) in patients with various diseases].
Topics: Adolescent; Adult; Angina Pectoris; Chronic Disease; Diabetes Mellitus; Female; Fibrin; Fibrinogen; Hematologic Diseases; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Myocardial Infarction; Neoplasms | 1972 |
[Fibrinolytic therapy in severe angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Blood Platelets; Blood Viscosity; Electrocardiography; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Streptokinase; Time Factors | 1971 |
[Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency].
Topics: Adult; Aged; Aging; Angina Pectoris; Antithrombins; Blood Coagulation; Coronary Disease; Female; Fibrinogen; Fibrinolysis; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Prothrombin; Thrombelastography; Thrombin | 1970 |
[Problem of the differential diagnosis and therapy of climacteric cardiopathy].
Topics: Adult; Aged; Aging; Angina Pectoris; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; C-Reactive Protein; Climacteric; Coronary Disease; Diagnosis, Differential; Electrocardiography; Estradiol; Female; Fibrinogen; Heart Diseases; Humans; Leukocyte Count; Male; Menopause; Methyltestosterone; Middle Aged; Myocardial Infarction; Pain; Serum Globulins; Testosterone | 1967 |
[On some clinical and humoral changes during the 3d week of disease with myocardial infarct].
Topics: 17-Ketosteroids; Adult; Aged; Angina Pectoris; Blood Sedimentation; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction; Retrospective Studies | 1968 |
[Studies on blood clotting disorders in patients with myocardial infarction and angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Blood Coagulation Disorders; Fibrinogen; Heparin; Humans; Middle Aged; Myocardial Infarction | 1968 |
[The diagnostic significance of plasma fibrinogen in myocardial infarct and the angina pectoris syndrome].
Topics: Adult; Aged; Angina Pectoris; Female; Fibrinogen; Humans; Male; Middle Aged; Myocardial Infarction | 1966 |